https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index en-au 5 Predictors of disability worsening in clinically isolated syndrome https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:28397 Wed 11 Apr 2018 15:14:13 AEST ]]> The Australian Multiple Sclerosis (MS) Immunotherapy Study: a prospective, multicentre study of drug utilisation using the MSBase platform https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:13692 Wed 11 Apr 2018 09:50:56 AEST ]]> Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:40611 Thu 11 Aug 2022 13:48:34 AEST ]]> Fingolimod after natalizumab and the risk of short-term relapse https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:20798 Sat 24 Mar 2018 08:05:59 AEDT ]]> Risk of relapse phenotype recurrence in multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:20329 Sat 24 Mar 2018 07:55:11 AEDT ]]> Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:46229 Mon 14 Nov 2022 12:25:51 AEDT ]]>